Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead Sciences completes acquisition of YM BioSciences
Yahoo/PR Newswire
Sat, 02/9/13 - 10:42 am
Tags:
Gilead Sciences, YM BioSciences, M&A
Foolish Preview: Gilead Earnings
Motley Fool
Sun, 02/3/13 - 11:41 am
Tags:
Gilead Sciences, earnings
Gilead Sciences Earnings: An Early Look
Motley Fool
Sat, 02/2/13 - 11:40 am
Tags:
Gilead Sciences
Analysis: Drug industry bets on new blockbusters in 2013
Reuters
Tue, 01/15/13 - 11:37 am
Tags:
Roche, GlaxoSmithKline, Eli Lilly, Biogen Idec, Gilead Sciences, Novo Nordisk
2012 Roundup -- HCV Treatments
Motley Fool
Sun, 12/30/12 - 12:15 pm
Tags:
HCV, Vertex Pharmaceuticals, Merck, Gilead Sciences, Abbott Laboratories, hepatitis C, Achillion, Idenix, JNJ, GSK
Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)
Investopedia
Sat, 12/29/12 - 09:42 am
Tags:
Celgene Corporation, Regeneron, Gilead Sciences
4 FDA Approvals in 1 Day
Motley Fool
Wed, 12/26/12 - 09:30 am
Tags:
FDA, drug approvals, Roche, Tamiflu, Gilead Sciences, Gattex, NPS Pharmaceuticals, Alexza, Adasuve, VariZIG, Cangene
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Tags:
Xtandi, Medivation, prostate cancer, Stribild, Gilead Sciences, HIV, Belviq, Arena Pharmaceuticals, obesity, weight loss, Qsymia, Vivus, Kyprolis, ONYX Pharmaceuticals, Multiple Myeloma, Omontys, Affymax, anemia, Linzess, irritable bowel syndrome, Ironwood Pharmaceuticals, Bosulif, chronic myeloid leukemia, Pfizer, Amyvid, Alzheimer's disease, Eli Lilly, Eylea, macular degeneration, Regeneron
European Commission approves oral granule formulation of Gilead Viread
Pharmaceutical Business Review
Sat, 12/15/12 - 12:57 pm
Tags:
Gilead Sciences, Viread, HIV, AIDS
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 12/15/12 - 11:33 am
Tags:
YM BioSciences, Gilead Sciences, M&A, Infinity Pharmaceuticals, Synta Pharmaceuticals
Gilead Sciences' Stock Dividend And What's Behind It
Seeking Alpha
Sat, 12/15/12 - 11:23 am
Tags:
Gilead Sciences
Gilead to buy YM BioSciences for about $465 million
Reuters
Wed, 12/12/12 - 10:02 am
Tags:
YM BioSciences, M&A, Gilead Sciences
Invest in the Great Progress of Hepatitis C
Motley Fool
Sat, 12/8/12 - 11:17 am
Tags:
hepatitis C, Gilead Sciences, sofosbuvir, Medivir, TMC435, ACH-1625, Achillion
Gilead Sciences Leads The Race In Developing A Hepatitis C Pill
Seeking Alpha
Sat, 12/8/12 - 11:04 am
Tags:
Gilead Sciences, hepatitis C, sofosbuvir
5 Drug Hopefuls That Are Going to Change Your Life: Part 2
Motley Fool
Sat, 11/24/12 - 12:01 pm
Tags:
Gilead Sciences, sofosbuvir, hepatitis C, Bristol-Myers Squibb, BMS-986094, Idenix, IDX-184, Abbott Laboratories, Achillion, ACH-3102
Gilead Stock Hits New 52-Week High
The Street
Sat, 11/24/12 - 11:35 am
Tags:
Gilead Sciences
This Week in Biotech: Part 1 (The Hep-C Chronicles)
Motley Fool
Sat, 11/17/12 - 01:47 pm
Tags:
Gilead Sciences, Abbott Laboratories, Idenix, Achillion, hepatitis C
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 11/17/12 - 01:46 pm
Tags:
Infinity, Sarepta Therapeutics, Gilead Sciences
For Hep C Investors, What Goes Around Comes Around
Motley Fool
Sat, 11/3/12 - 11:28 am
Tags:
hepatitis C, Vertex Pharmaceuticals, Gilead Sciences, Abbott Laboratories, Idenix, Achillion
Why These 3 Biotech Stocks Are Winning
Motley Fool
Sat, 10/27/12 - 11:32 am
Tags:
Cyclacel, Gilead Sciences, Amarin

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.